0001567619-21-012046.txt : 20210614
0001567619-21-012046.hdr.sgml : 20210614
20210614144704
ACCESSION NUMBER: 0001567619-21-012046
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
EFFECTIVENESS DATE: 20210614
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pacylex Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001866841
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-402780
FILM NUMBER: 211014207
BUSINESS ADDRESS:
STREET 1: 10230 JASPER AVENUE, SUITE 4000
CITY: EDMONTON
STATE: A0
ZIP: T5J 4P6
BUSINESS PHONE: 780-264-4295
MAIL ADDRESS:
STREET 1: 10230 JASPER AVENUE, SUITE 4000
CITY: EDMONTON
STATE: A0
ZIP: T5J 4P6
D
1
primary_doc.xml
X0708
D
LIVE
0001866841
Pacylex Pharmaceuticals Inc.
10230 JASPER AVENUE, SUITE 4000
EDMONTON
A0
ALBERTA, CANADA
T5J 4P6
780-264-4295
CANADA (FEDERAL LEVEL)
None
None
Corporation
true
Cindy
Jacobs
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A0
ALBERTA, CANADA
T5J 4P6
Director
Mark
Huson
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A0
ALBERTA, CANADA
T5J 4P6
Director
Michael
Weickert
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A0
ALBERTA, CANADA
T5J 4P6
Executive Officer
Director
Luc
G.
Berthiaume
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A1
BRITISH COLUMBIA, CANADA
T5J 4P6
Director
John
Mackey
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A0
ALBERTA, CANADA
T5J 4P6
Director
Ryan
Heit
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A0
ALBERTA, CANADA
T5J 4P6
Executive Officer
Ajit
Gill
c/o Pacylex Pharmaceuticals Inc.
10230 Jasper Avenue, Suite 4000
Edmonton
A0
ALBERTA, CANADA
T5J 4P6
Director
Pharmaceuticals
Decline to Disclose
- 06c
false
2021-05-28
false
true
true
false
0
7184198
7184198
0
This filing covers, in part, the sale of common shares issued as a result of the conversion of promissory notes.
false
6
0
0
0
false
Pacylex Pharmaceuticals Inc.
/s/ Ryan Heit
Ryan Heit
Chief Operating Officer
2021-06-14